A turning point in hepatology? EASL reflects on the first approved drug for MASH

Sven Francque; Aleksander Krag; Debbie L. Shawcross; Shira Zelber-Sagi

doi:10.1016/j.jhep.2024.04.036

A turning point in hepatology? EASL reflects on the first approved drug for MASH

Sven Francque, Aleksander Krag, Debbie L. Shawcross, Shira Zelber-Sagi

School of Public Health

University of Haifa

Research output: Contribution to journal › Editorial

Original language	American English
Pages (from-to)	192-194
Number of pages	3
Journal	Journal of Hepatology
Volume	81
Issue number	2
Early online date	16 May 2024
DOIs	https://doi.org/10.1016/j.jhep.2024.04.036
State	Published - Aug 2024

All Science Journal Classification (ASJC) codes

Hepatology

Access to Document

10.1016/j.jhep.2024.04.036

http://www.journal-of-hepatology.eu/article/S0168827824003404/pdf

Cite this

@article{17dfad3737834da79db4a183a565daec,

title = "A turning point in hepatology? EASL reflects on the first approved drug for MASH",

author = "Sven Francque and Aleksander Krag and Shawcross, \{Debbie L.\} and Shira Zelber-Sagi",

year = "2024",

month = aug,

doi = "10.1016/j.jhep.2024.04.036",

language = "American English",

volume = "81",

pages = "192--194",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - A turning point in hepatology? EASL reflects on the first approved drug for MASH

AU - Francque, Sven

AU - Krag, Aleksander

AU - Shawcross, Debbie L.

AU - Zelber-Sagi, Shira

PY - 2024/8

Y1 - 2024/8

UR - http://www.scopus.com/inward/record.url?scp=85194410769&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2024.04.036

DO - 10.1016/j.jhep.2024.04.036

M3 - Editorial

C2 - 38762170

SN - 0168-8278

VL - 81

SP - 192

EP - 194

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 2

ER -

A turning point in hepatology? EASL reflects on the first approved drug for MASH

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this